These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis. Chalmers JD; Moffitt KL; Suarez-Cuartin G; Sibila O; Finch S; Furrie E; Dicker A; Wrobel K; Elborn JS; Walker B; Martin SL; Marshall SE; Huang JT; Fardon TC Am J Respir Crit Care Med; 2017 May; 195(10):1384-1393. PubMed ID: 27911604 [TBL] [Abstract][Full Text] [Related]
3. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis. Chalmers JD; Haworth CS; Metersky ML; Loebinger MR; Blasi F; Sibila O; O'Donnell AE; Sullivan EJ; Mange KC; Fernandez C; Zou J; Daley CL; N Engl J Med; 2020 Nov; 383(22):2127-2137. PubMed ID: 32897034 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques. Oriano M; Terranova L; Sotgiu G; Saderi L; Bellofiore A; Retucci M; Marotta C; Gramegna A; Miglietta D; Carnini C; Marchisio P; Chalmers JD; Aliberti S; Blasi F Pulm Pharmacol Ther; 2019 Dec; 59():101856. PubMed ID: 31626976 [TBL] [Abstract][Full Text] [Related]
12. Airway Inflammation in Children with Primary Ciliary Dyskinesia. Sagel SD; Kupfer O; Wagner BD; Davis SD; Dell SD; Ferkol TW; Hoppe JE; Rosenfeld M; Sullivan KM; Tiddens HAWM; Knowles MR; Leigh MW Ann Am Thorac Soc; 2023 Jan; 20(1):67-74. PubMed ID: 35984413 [No Abstract] [Full Text] [Related]
13. Symptoms of airway reflux predict exacerbations and quality of life in bronchiectasis. Mandal P; Morice AH; Chalmers JD; Hill AT Respir Med; 2013 Jul; 107(7):1008-13. PubMed ID: 23683772 [TBL] [Abstract][Full Text] [Related]
14. A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile. Perea L; Cantó E; Suarez-Cuartin G; Aliberti S; Chalmers JD; Sibila O; Vidal S Chest; 2021 May; 159(5):1758-1767. PubMed ID: 33217421 [TBL] [Abstract][Full Text] [Related]
15. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis. Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770 [TBL] [Abstract][Full Text] [Related]
16. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805 [TBL] [Abstract][Full Text] [Related]
17. Sputum elastase in steady-state bronchiectasis. Tsang KW; Chan K; Ho P; Zheng L; Ooi GC; Ho JC; Lam W Chest; 2000 Feb; 117(2):420-6. PubMed ID: 10669685 [TBL] [Abstract][Full Text] [Related]
18. Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study. Georgakopoulou VE; Trakas N; Damaskos C; Garmpis N; Karakou E; Chatzikyriakou R; Lambrou P; Tsiafaki X Cureus; 2020 Aug; 12(8):e9728. PubMed ID: 32944447 [TBL] [Abstract][Full Text] [Related]
19. Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients. Terranova L; Risé P; Gramegna A; Pinna C; Agostoni C; Syrén ML; Turolo S; Marchisio P; Amati F; Aliberti S; Sala A; Blasi F Respir Res; 2022 Dec; 23(1):363. PubMed ID: 36539829 [TBL] [Abstract][Full Text] [Related]
20. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]